ICR
INTELICARE FPO [ICR]
Healthcare · ASX Small Cap
$0.0150 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical38
Catalyst45
Sentiment50
Fundamental32
Momentum67
Risk Gate32
Get alerts when ICR's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Took a hit — down 11.8% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
- Critical cash runway (1.6 quarters)
- Moderate P/S ratio (9.9x)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Strong long-term momentum — up 186% over the past year (excluding last month)
- Penny stock risk ($0.015)
- Beneish M-Score -0.86 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-2.86%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ICR
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW NWR Virtual Healthcare Conference Details
NONE CEO Appointment
NONE Landmark $8.8m Commercial Agreement Completed with mecwacare
NONE Half Yearly Report and Accounts
NEGATIVE Trading Halt
Recent ASX Announcements
| 2026-03-25 | NWR Virtual Healthcare Conference Details |
| 2026-03-16 | CEO Appointment PRICE SENSITIVE |
| 2026-03-11 | Landmark $8.8m Commercial Agreement Completed with mecwacare PRICE SENSITIVE |
| 2026-03-10 | Trading Halt PRICE SENSITIVE |
| 2026-02-26 | Half Yearly Report and Accounts PRICE SENSITIVE |
Key Metrics
$9.3M
Market Cap
923K
Avg Volume
1.6x
Vol Ratio
$0.01 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-1420.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 56% |
| L | Leader vs Laggard | laggard | RS: -8 |
| I | Institutional Sponsorship | weak | Inst: 10% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #108 of 117 · Sector avg: 46
View all Healthcare signals →Track ICR and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required